While most NASDAQ
The market news is full of how awful it’s been for the big name tech and social media names. Tim Cook’s Apple
That didn’t stop ADMA Biologics from making the new 52-week highs list. It was the same thing for Grocery Outlet Holding and for Chinook Therapies. Buyers couldn’t get enough of these 3 stocks. Who are they and what do they do?
First, for comparison’s sake, here’s the NASDAQ Composite’s daily chart, up slightly for the week but nowhere near 52-week or even just 2022 highs.
Now look at Adma’s daily price chart:
ADMA is in the right sector at the right time, it would seem. That’s an upward move from the late November low down there near 1 to last week’s high of 2.20.
According to their website, the company “is an end-to-end commercial biopharmaceutical company committed to manufacturing, marketing and developing specialty plasma-derived products for the prevention and treatment of infectious diseases in the immune compromised and other patients at risk for infection.”
CEO Adam Grossman is a graduate of American University where received a B. S. in Business Administration. He brought ADMA public back in 2012.
Grocery Outlet’s daily price chart is here:
From 22 in early November, 2021 up to the current price of 40.15, that’s an extraordinary move while other NASDAQ stocks have struggled. The Emery, California-based company started with just one store in 1956 and now operates 400 locations nationwide. Chief Executive Officer Eric Lindberg attended Hampton-Sydney College in Virginia where he received a 1993 B. A. in Economics and Spanish.
Here’s the daily price chart of Chinook Therpeutics:
That’s a classic “break out” pattern as the price made it above the previous resistance levels from November, 2021 forward. On its website, the company says it makes “precision medicines for kidney diseases.” Chinook, founded in 2019, has corporate offices in Vancouver, British Columbia, in Seattle, Washington and in Berkeley, California. The CEO is Eric Dobmeier who graduated Princeton and received a J. D. from the University of California, Berkeley School of Law.
Stocks making new highs do not necessarily continue to do so. The big stocks like Apple, Microsoft and Meta Platform might begin to re-assert leadership. The point is: these smaller names hitting higher highs at a time when very few are doing so is rare and notable.
Not investment advice. For educational purposes only.
Software Can Determine Which Care Your Medicare Advantage Plan Covers
Will Protests In Paris Change Macron’s Mind?
It’s Time For Some Serious Railroad Regulation